Form 4 for GOSS Gossamer Bio, Inc.
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-16 · accession 0001728117-22-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-17 | 2022-03-16 | GOSS | Aranda Richard | Chief Medical Off | S - Sale | $8.28 | -6,278 | 211.7K | -3% | -$52.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-16 | S | D | 6,278 | $8.28 | 211,675 | D | — | — | (F1) Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. (F2) This transaction was executed in multiple trades at prices ranging from $8.27 to $8.42 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |